Literature DB >> 28992856

Cancer-Related Fatigue in Cancer Survivorship.

Chidinma C Ebede1, Yongchang Jang1, Carmen P Escalante2.   

Abstract

Cancer-related fatigue (CRF) significantly interferes with usual functioning because of the distressing sense of physical, emotional, and cognitive exhaustion. Assessment of CRF is important and should be performed during the initial cancer diagnosis, throughout cancer treatment, and after treatment using a fatigue scoring scale (mild-severe). The general approach to CRF management applies to cancer survivors at all fatigue levels and includes education, counseling, and other strategies. Nonpharmacologic interventions include psychosocial interventions, exercise, yoga, physically based therapy, dietary management, and sleep therapy. Pharmacologic interventions include psychostimulants. Antidepressants may also benefit when CRF is accompanied by depression.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer survivors; Cancer-related fatigue; Cognitive behavioral therapy; Exercise; Psycho-educational therapy; Psychostimulants; Screening; Yoga

Mesh:

Substances:

Year:  2017        PMID: 28992856     DOI: 10.1016/j.mcna.2017.06.007

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  37 in total

Review 1.  The Role of Physical Activity in Managing Fatigue in Cancer Survivors.

Authors:  Bernat-Carles Serdà I Ferrer; Eline van Roekel; Brigid M Lynch
Journal:  Curr Nutr Rep       Date:  2018-09

2.  Fatigue Symptoms During the First Year Following ARDS.

Authors:  Karin J Neufeld; Jeannie-Marie S Leoutsakos; Haijuan Yan; Shihong Lin; Jeffrey S Zabinski; Victor D Dinglas; Megan M Hosey; Ann M Parker; Ramona O Hopkins; Dale M Needham
Journal:  Chest       Date:  2020-04-15       Impact factor: 9.410

Review 3.  The effect of music therapy interventions on fatigue in patients with hematological cancers: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Merve Gozde Sezgin; Hicran Bektas
Journal:  Support Care Cancer       Date:  2022-06-11       Impact factor: 3.603

4.  Potential Drug Interactions Between Psychotropics and Intravenous Chemotherapeutics Used by Patients With Cancer.

Authors:  Eric Diego Turossi-Amorim; Bruna Camargo; Diego Zapelini do Nascimento; Fabiana Schuelter-Trevisol
Journal:  J Pharm Technol       Date:  2022-02-18

Review 5.  Palliative Care for Cancer Survivors.

Authors:  Sydney M Dy; Sarina R Isenberg; Nebras Abu Al Hamayel
Journal:  Med Clin North Am       Date:  2017-11       Impact factor: 5.456

Review 6.  Antidepressants for the treatment of depression in people with cancer.

Authors:  Giovanni Ostuzzi; Faith Matcham; Sarah Dauchy; Corrado Barbui; Matthew Hotopf
Journal:  Cochrane Database Syst Rev       Date:  2018-04-23

7.  Psychometric properties of the Korean version of the Pittsburgh Fatigability Scale in breast cancer survivors.

Authors:  Min Kyeong Jang; Sue Kim; Chang Gi Park; Eileen G Collins; Lauretta T Quinn; Nancy W Glynn; Carol Estwing Ferrans
Journal:  Health Qual Life Outcomes       Date:  2021-07-12       Impact factor: 3.186

8.  Case Report: Dynamic Interdependencies Between Complementary and Alternative Medicine (CAM) Practice, Urinary Interleukin-6 Levels, and Fatigue in a Breast Cancer Survivor.

Authors:  Magdalena Singer; Michaela Ott; Harald R Bliem; Birgit Hladschik-Kermer; Francisco M Ocaña-Peinado; Emil Chamson; Christian Schubert
Journal:  Front Psychiatry       Date:  2021-06-02       Impact factor: 4.157

9.  The prevalence of depressive disorder and its association in Thai cervical cancer patients.

Authors:  Nuntaporn Karawekpanyawong; Kewalee Kaewkitikul; Benchalak Maneeton; Narong Maneeton; Sitthicha Siriaree
Journal:  PLoS One       Date:  2021-06-21       Impact factor: 3.240

10.  Factors to improve distress and fatigue in Cancer survivorship; further understanding through text analysis of interviews by machine learning.

Authors:  Kyungmi Yang; Jina Kim; Mison Chun; Mi Sun Ahn; Eunae Chon; Jinju Park; Mijin Jung
Journal:  BMC Cancer       Date:  2021-06-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.